Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 02-Feb-11 5:57 PM View:  | Rooker D Gregory Director | King Pharmaceuticals Inc. (KG) | 31-Jan-11 | Disposition (change in control) | 1,350 | -- | -- | (100%) 1.35K to 0 | |
| 02-Feb-11 6:00 PM View: | Markison Brian A President and CEO Director | King Pharmaceuticals Inc. (KG) | 31-Jan-11 | Disposition | 200,760 | -- | -- | (27%) 748.12K to 547.36K | |
| 02-Feb-11 6:04 PM View: | Carter Eric G Chief Science Officer | King Pharmaceuticals Inc. (KG) | 31-Jan-11 | Disposition (change in control) | 135,427 | -- | -- | (100%) 135.43K to 0 | |
| 02-Feb-11 5:59 PM View: | Moyer Charles Director | King Pharmaceuticals Inc. (KG) | 31-Jan-11 | Disposition (change in control) | 16,012 | -- | -- | (100%) 16.01K to 0 | |
| 02-Feb-11 6:05 PM View: | Brouillette Frederick Jr Corporate Compliance Officer | King Pharmaceuticals Inc. (KG) | 31-Jan-11 | Disposition | 18,760 | -- | -- | (19%) 96.3K to 77.54K | |
| 02-Feb-11 6:01 PM View: | Incarnati Philip A Director | King Pharmaceuticals Inc. (KG) | 31-Jan-11 | Disposition (change in control) | 38,358 | -- | -- | (100%) 38.36K to 0 | |
| 02-Feb-11 5:56 PM View: | Wood Ted G Director | King Pharmaceuticals Inc. (KG) | 31-Jan-11 | Disposition (change in control) | 59,460 | -- | -- | (100%) 59.46K to 0 | |
| 02-Feb-11 6:04 PM View: | Carter Eric G Chief Science Officer | King Pharmaceuticals Inc. (KG) | 31-Jan-11 | Disposition | 38,740 | -- | -- | (22%) 174.17K to 135.43K | |
| 02-Feb-11 6:06 PM View: | Bailey Jeffrey Allen Chief Commercial Officer | King Pharmaceuticals Inc. (KG) | 31-Jan-11 | Disposition | 40,000 | -- | -- | (100%) 40.0K to 0 | |
| 02-Feb-11 6:03 PM View: | Elrod James W Chief Legal Officer, A. Sec. | King Pharmaceuticals Inc. (KG) | 31-Jan-11 | Disposition | 41,770 | -- | -- | (20%) 207.45K to 165.68K | |
| 02-Feb-11 6:00 PM View: | Jordan Gregory D Director | King Pharmaceuticals Inc. (KG) | 31-Jan-11 | Disposition (change in control) | 41,679 | -- | -- | (100%) 41.68K to 0 | |
| 02-Feb-11 5:55 PM View: | Squicciarino Joseph Chief Financial Officer | King Pharmaceuticals Inc. (KG) | 31-Jan-11 | Disposition | 74,740 | -- | -- | (18%) 422.43K to 347.69K | |
| 02-Feb-11 5:57 PM View: | Rooker D Gregory Director | King Pharmaceuticals Inc. (KG) | 31-Jan-11 | Disposition (change in control) | 53,145 | -- | -- | (98%) 54.49K to 1.35K | |
| 02-Feb-11 6:05 PM View: | Brouillette Frederick Jr Corporate Compliance Officer | King Pharmaceuticals Inc. (KG) | 31-Jan-11 | Disposition (change in control) | 77,543 | -- | -- | (100%) 77.54K to 0 | |
| 02-Feb-11 6:05 PM View: | Bruce Eric J President, Animal Health | King Pharmaceuticals Inc. (KG) | 31-Jan-11 | Disposition (change in control) | 170,709 | -- | -- | (100%) 170.71K to 0 | |
| 02-Feb-11 6:01 PM View: | Greetham Elizabeth M Director | King Pharmaceuticals Inc. (KG) | 31-Jan-11 | Disposition (change in control) | 12,794 | -- | -- | (100%) 12.79K to 0 | |
| 02-Feb-11 5:55 PM View: | Squicciarino Joseph Chief Financial Officer | King Pharmaceuticals Inc. (KG) | 31-Jan-11 | Disposition (change in control) | 347,687 | -- | -- | (100%) 347.69K to 0 | |
| 02-Feb-11 5:56 PM View: | Schaffer Derace L Director | King Pharmaceuticals Inc. (KG) | 31-Jan-11 | Disposition (change in control) | 10,000 | -- | -- | (100%) 10.0K to 0 | |
| 02-Feb-11 6:03 PM View: | Elrod James W Chief Legal Officer, A. Sec. | King Pharmaceuticals Inc. (KG) | 31-Jan-11 | Disposition (change in control) | 165,678 | -- | -- | (100%) 165.68K to 0 | |
| 02-Feb-11 6:00 PM View: | Markison Brian A President and CEO Director | King Pharmaceuticals Inc. (KG) | 31-Jan-11 | Disposition (change in control) | 547,360 | -- | -- | (100%) 547.36K to 0 | |
| 02-Feb-11 6:05 PM View: | Bruce Eric J President, Animal Health | King Pharmaceuticals Inc. (KG) | 31-Jan-11 | Disposition | 38,870 | -- | -- | (19%) 209.58K to 170.71K | |
| 11-Jan-11 5:11 PM View: | Carter Eric G Chief Science Officer | King Pharmaceuticals Inc. (KG) | 07-Jan-11 | Grant | 16,260 | -- | -- | 14% 119.97K to 136.23K | |
| 11-Jan-11 5:10 PM View: | Elrod James W Chief Legal Officer, A. Sec. | King Pharmaceuticals Inc. (KG) | 07-Jan-11 | Grant | 17,540 | -- | -- | 15% 118.73K to 136.27K | |
| 11-Jan-11 5:09 PM View: | Squicciarino Joseph Chief Financial Officer | King Pharmaceuticals Inc. (KG) | 07-Jan-11 | Grant | 32,060 | -- | -- | 10% 315.55K to 347.61K | |
| 11-Jan-11 5:11 PM View: | Bruce Eric J President, Animal Health | King Pharmaceuticals Inc. (KG) | 07-Jan-11 | Grant | 16,720 | -- | -- | 11% 153.86K to 170.58K | |
| 11-Jan-11 5:09 PM View: | Markison Brian A President and CEO Director | King Pharmaceuticals Inc. (KG) | 07-Jan-11 | Grant | 86,260 | -- | -- | 19% 460.6K to 546.86K | |
| 11-Jan-11 5:11 PM View: | Brouillette Frederick Jr Corporate Compliance Officer | King Pharmaceuticals Inc. (KG) | 07-Jan-11 | Grant | 8,920 | -- | -- | 13% 66.58K to 75.5K | |
| 20-Jan-11 6:27 PM View: | Markison Brian A President and CEO Director | King Pharmaceuticals Inc. (KG) | 31-Dec-10 | Option Exercise | 201,260 | -- | -- | 37% 546.86K to 748.12K | |
| 20-Jan-11 6:17 PM View: | Bruce Eric J President, Animal Health | King Pharmaceuticals Inc. (KG) | 31-Dec-10 | Option Exercise | 39,000 | -- | -- | 23% 170.58K to 209.58K | |
| 20-Jan-11 6:15 PM View: | Brouillette Frederick Jr Corporate Compliance Officer | King Pharmaceuticals Inc. (KG) | 31-Dec-10 | Option Exercise | 20,800 | -- | -- | 28% 75.5K to 96.3K | |
| 20-Jan-11 6:29 PM View: | Squicciarino Joseph Chief Financial Officer | King Pharmaceuticals Inc. (KG) | 31-Dec-10 | Option Exercise | 74,820 | -- | -- | 22% 347.61K to 422.43K | |
| 20-Jan-11 6:19 PM View: | Carter Eric G Chief Science Officer | King Pharmaceuticals Inc. (KG) | 31-Dec-10 | Option Exercise | 37,940 | -- | -- | 28% 136.23K to 174.17K | |
| 20-Jan-11 6:22 PM View: | Elrod James W Chief Legal Officer, A. Sec. | King Pharmaceuticals Inc. (KG) | 31-Dec-10 | Option Exercise | 40,940 | -- | -- | 25% 166.51K to 207.45K | |
| 17-Dec-10 5:04 PM View: | Markison Brian A President and CEO Director | King Pharmaceuticals Inc. (KG) | 14-Dec-10 | Payment of Exercise | 92,700 | $14.22 | $1,318,190.00 | (17%) 553.3K to 460.6K | < 1% |
| 17-Dec-10 5:06 PM View: | Brouillette Frederick Jr Corporate Compliance Officer | King Pharmaceuticals Inc. (KG) | 14-Dec-10 | Payment of Exercise | 18,030 | $14.22 | $256,387.00 | (21%) 84.61K to 66.58K | < 1% |
| 17-Dec-10 5:05 PM View: | Bruce Eric J President, Animal Health | King Pharmaceuticals Inc. (KG) | 14-Dec-10 | Payment of Exercise | 26,244 | $14.22 | $373,190.00 | (15%) 180.1K to 153.86K | < 1% |
| 17-Dec-10 5:02 PM View: | Squicciarino Joseph Chief Financial Officer | King Pharmaceuticals Inc. (KG) | 14-Dec-10 | Payment of Exercise | 37,080 | $14.22 | $527,278.00 | (11%) 352.63K to 315.55K | < 1% |
| 01-Dec-10 5:03 PM View: | Carter Eric G Chief Science Officer | King Pharmaceuticals Inc. (KG) | 29-Nov-10 | Payment of Exercise | 40,426 | $14.15 | $572,028.00 | (25%) 160.39K to 119.97K | 0% |
| 01-Dec-10 5:04 PM View: | Elrod James W Chief Legal Officer, Secretary | King Pharmaceuticals Inc. (KG) | 29-Nov-10 | Payment of Exercise | 36,742 | $14.15 | $519,899.00 | (20%) 185.71K to 148.97K | 0% |
| 02-Feb-11 5:57 PM View: | Rooker D Gregory Director | King Pharmaceuticals Inc. (KG) | 29-Nov-10 | Gift | 7,067 | -- | -- | (11%) 61.56K to 54.49K | |
| 02-Feb-11 6:03 PM View: | Deavenport Earnest W Jr Director | King Pharmaceuticals Inc. (KG) | 11-Nov-10 | Gift | 43,179 | -- | -- | (100%) 43.18K to 0 | |
| 02-Feb-11 6:01 PM View: | Incarnati Philip A Director | King Pharmaceuticals Inc. (KG) | 07-Oct-10 | Gift | 38,358 | -- | -- | (50%) 76.72K to 38.36K | |
| 01-Sep-10 5:08 PM View: | Bailey Jeffrey Allen Chief Commercial Officer | King Pharmaceuticals Inc. (KG) | 30-Aug-10 | Grant | 40,000 | -- | -- | 100% 0 to 40.0K | |
| 03-Jun-10 5:05 PM View: | Moyer Charles Director | King Pharmaceuticals Inc. (KG) | 01-Jun-10 | Market Sale (Planned) | 7,000 | $8.57 | $59,990.00 | (18%) 39.21K to 32.21K | 5% |
| 18-May-10 8:37 PM View: | Moyer Charles Director | King Pharmaceuticals Inc. (KG) | 14-May-10 | Grant | 16,201 | $8.95 | $144,999.00 | 70% 23.01K to 39.21K | (1%) |
| 18-May-10 8:36 PM View: | Schaffer Derace L Director | King Pharmaceuticals Inc. (KG) | 14-May-10 | Grant | 16,201 | $8.95 | $144,999.00 | 510% 3.17K to 19.38K | (1%) |
| 18-May-10 8:41 PM View: | Deavenport Earnest W Jr Director | King Pharmaceuticals Inc. (KG) | 14-May-10 | Grant | 16,201 | $8.95 | $144,999.00 | 38% 43.18K to 59.38K | (1%) |
| 18-May-10 8:38 PM View: | Jordan Gregory D Director | King Pharmaceuticals Inc. (KG) | 14-May-10 | Grant | 16,201 | $8.95 | $144,999.00 | 39% 41.68K to 57.88K | (1%) |
| 18-May-10 8:40 PM View: | Greetham Elizabeth M Director | King Pharmaceuticals Inc. (KG) | 14-May-10 | Grant | 16,201 | $8.95 | $144,999.00 | 39% 41.68K to 57.88K | (1%) |
| 18-May-10 8:42 PM View: | Crutchfield Kevin S Director | King Pharmaceuticals Inc. (KG) | 14-May-10 | Grant | 16,201 | $8.95 | $144,999.00 | 510% 3.17K to 19.38K | (1%) |
